SPA
DGX icon

Sherbrooke Park Advisers’s Quest Diagnostics DGX Stock Holding History

Sherbrooke Park Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,571
Closed -$490K – 292
2025
Q3 		$490K Buy
+2,571
New +$456K 0.23% 172
2024
Q4 		– Sell
-1,975
Closed -$307K – 860
2024
Q3 		$307K Sell
1,975
-818
-29% -$122K 0.07% 556
2024
Q2 		$382K Buy
+2,793
New +$382K 0.07% 523
2023
Q4 		– Sell
-5,356
Closed -$653K – 516
2023
Q3 		$653K Buy
+5,356
New +$714K 0.21% 183

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sherbrooke Park Advisers's DGX Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 2,571 shares — an estimated $490K sold.

Sherbrooke Park Advisers first reported a position in DGX in Q3 2023 and held it in 4 quarters. The position peaked at $653K in Q3 2023. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 2,571 Quest Diagnostics shares in Q4 2025, an estimated $490K.
  • Sherbrooke Park Advisers first reported a position in Quest Diagnostics in Q3 2023 and held it in 4 quarters.
  • Sherbrooke Park Advisers's Quest Diagnostics position peaked at $653K in Q3 2023.
  • 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.